Leverone Jason A. sold 302 shares of OnKure Therapeutics, Inc. at $2.97 for −$898 on Sep 21, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Financial Officer
Chief Financial Officer
Filed Sep 23, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$898.21Shares × reported price
Shares traded
302Class A Common Stock
Price per share
$2.97Reported price. Read footnotes for ranges.
% of reported position traded
1.61%This security and ownership context
Holdings after
18,500Direct
Trade date
Sep 21, 2026Sell
Filed
Sep 23, 2026, 4:52 PM ET2-day reporting delay
Accession
0001692747-26-000005Code S · Transaction 228440
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 18,802 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

OKUR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
OKUR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.3%1w ago 0%1d ago 0%
Returns since7d −29%30d −33%90d180d1y

Footnotes in full

F1: These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan. F2: This transaction was executed in multiple trades at prices ranging from $2.95 to $3.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.